New Key Statistics Module, Z-Score and F-Score
NAS:TXMD Key Ratios
| Market Cap $ M | 21.45 |
| Enterprise Value $ M | 22.77 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 0.79 |
| Price/Sales | 21.71 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | -- |
| EPS (TTM) $ | -0.53 |
| Beneish M-Score | 174.64 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -- |
| y-y EBITDA Growth Rate % | -112.40 |
| EV-to-EBIT | -3.94 |
| EV-to-EBITDA | -4.85 |
| PEG | -- |
| Shares Outstanding M | 11.53 |
| Net Margin (%) | -610.94 |
| Operating Margin % | -572.79 |
| Pre-tax Margin (%) | -489.66 |
| Quick Ratio | 2.03 |
| Current Ratio | 2.03 |
| ROA % (ttm) | -13.25 |
| ROE % (ttm) | -21.00 |
| ROIC % (ttm) | -15.37 |
| Dividend Yield % | -- |
| Altman Z-Score | -32.41 |
TXMD Number of Guru Trades
TXMD Volume of Guru Trades
Gurus Latest Trades with NAS:TXMD
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:TXMD is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
TherapeuticsMD Inc Insider Transactions
No Available Data
News about NAS:TXMD
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers